IP Library Granted Patent US 6,844,179
Granted Patent B1
US 6,844,179 · App. 10/130,158 · Granted Jan 18, 2005

Protein and DNA thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,844,179
App. No.
10/130,158
Granted
Jan 18, 2005
Kind
B1
Abstract

The protein of the present invention and a DNA encoding the same can be used as therapeutic/prophylactic agents for diseases such as infectious diseases. The protein of the present invention is also useful as a reagent for screening a compound or its salt capable of promoting or inhibiting the activity of the protein of the present invention. Furthermore, a compound or its salt inhibiting the activity of the protein of the present invention and a neutralization antibody inhibiting the activity of the protein of the present invention can also be used as therapeutic/prophylactic agents for diseases such as bronchial asthma, chronic obstructive pulmonary disease, etc.

Claims (9)

1. An isolated protein having the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof.

2. An isolated signal peptide having the amino acid sequence represented by SEQ ID NO: 2, or a salt thereof.

3. An isolated polynucleotide comprising a DNA sequence encoding the protein according to claim 1 and having the base sequence represented by SEQ ID NO:3.

4. An isolated polynucleotide comprising a DNA sequence encoding the signal peptide according to claim 1 and having the base sequence represented by SEQ ID NO:4.

5. A recombinant vector comprising the DNA sequence according to claim 3 .

6. A transformant transformed with the recombinant vector according to claim 5 .

7. A method of manufacturing the protein according to claim 1 or a salt thereof, which comprises culturing a transformed host cell comprising an expressible DNA expression vector encoding for said protein, under conditions suitable for the expression of said protein for sufficient time to express said protein, and collecting the same.

8. A pharmaceutical comprising the protein according to claim 1 or a salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.

9. A pharmaceutical comprising the DNA according to claim 3 , and a pharmaceutically acceptable carrier, excipient or diluent.

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2002
From: NAKANISHI, ATSUSHI; MORITA, SHIGERU
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 013839/0834 →